Results of a support programme for treatment of overweight and obese patients with orlistat

Article English OPEN
Kobbevik, Katrin ; Gisletun, U. ; Hansson, F ; Tonstad, S (2005)
  • Publisher: Co-Action Publishing
  • Journal: Food & Nutrition Research (issn: 1654-661X, eissn: 1654-6628)
  • Related identifiers: doi: 10.3402/fnr.v49i4.1544

Background: Overweight and obesity are reaching epidemic proportions, and a variety of therapeutic countermeasures is needed. This article describes a support programme for orlistat. Methods: Physicians who prescribed orlistat could refer their patients to a support programme provided by the manufacturer. A clinical nutritionist evaluated the patient’s diet and gave advice and motivational support during approximately seven telephone consultations a year. Design: A cohort study. Results: Of 3526 patients (81.5% women and 18.5% men) whose first contact with the nutritionist was recorded between April 2001 and July 2004, 3023 had at least one follow-up consultation. The mean initial body mass index (BMI) was 33.7 (SD 9.0). Of men and women, 90% and 80%, respectively, met the Norwegian Pharmaceutical Product Compendium criteria for orlistat. The remaining patients had a BMI that was too low or no reported risk factors. Of the 2456 patients who reported their weight at two or more consultations, 70% achieved a
  • References (15)
    15 references, page 1 of 2

    1. Forebygging og behandling av overvekt/fedme i helsetjenesten. Oslo: Sosial- og Helsedirektoratet; 2004.

    2. Goldstein DJ. Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord 1992; 16: 397 /415.

    3. Torgerson JS, Hauptman J, Boldrin MN, Sjo¨ stro¨ m L. Xenical in the Prevention of Diabetes in Obese Subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004; 27: 155 /61.

    4. Mullen PD, Simons-Morton DG, Ramirez G, Frankowski RF, Green LW, Mains DA. A metaanalysis of trials evaluating patient education and counseling for three groups of preventive health behaviors. Patient Educ Couns 1997; 32: 157 /73.

    5. Nawaz H, Adams ML, Katz DL. Weight loss counseling by health care providers. Am J Public Health 1999; 89: 764 /7.

    6. Karvetti RL, Hakala P. A seven-year follow-up of a weight reduction programme in Finnish primary health care. Eur J Clin Nutr 1992; 46: 743 /52.

    7. Tonstad S, Birkeland KI. Fedmeepidemien / har slankepiller en plass i behandlingen? Tidsskr Nor Laegefor 2000; 120: 1997 /2001.

    8. Stewart M, Brown JB, Weston WW, McWhinney IR, McWilliam CL, Freeman TR. Patient-centered medicine. Transforming the clinical method. Thousand Oaks, CA: Sage; 1995.

    9. Pekkarinen M. Methodology in the collection of food consumption data. World Rev Nutr Diet 1970; 12: 145 /71.

    10. Norske naeringsstoffanbefalinger. Oslo: Statens ernaeringsra˚d; 1997.

  • Metrics
    No metrics available
Share - Bookmark